The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

The tariffs imposed by Trump were seen by some as an existential threat to the auto sector. Arthur Laffer, whom Trump gave ...

WASHINGTON (AP) — The Trump administration has frozen, stalled or otherwise disrupted some $430 billion in federal funds — ...

More than the immediate rewards, “vacations provide a buffer against chronic stress and inflammation — both of which wreak ...

In addition to risking indigestion, you’re more likely to overeat because the fullness trigger hasn’t had time to activate ...

According to halacha, or traditional Jewish law, milk is only kosher if it comes from a kosher animal. One way to ensure that ...

WARREN, Mich. (AP) — President Donald Trump is holding a rally in Michigan on Tuesday to mark the first 100 days of his ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...